Arctic Therapeutics | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Development
Email & Communication
Keywords & Focus Areas
Arctic Therapeutics
Overview
Arctic Therapeutics is a clinical-stage biopharmaceutical company focused on drug discovery and development. Founded in 2015, the organization leverages genetic research to address both rare and common diseases with significant unmet medical needs. Originating from the Center for Applied Genomics, it utilizes a genealogical database of Icelanders to analyze genetic causes of diseases, facilitating the creation of innovative therapies.
The company is dedicated to treating and potentially preventing critical diseases through advanced genetic sequencing, bioinformatics, and artificial intelligence. It collaborates closely with academic institutions and industry partners to enhance its drug pipeline. Notable candidates include AT-001, aimed at preventing harmful amyloid protein aggregation in the brain, and AT-004, targeting inflammatory skin diseases. The organization serves patients with various conditions, including genetic diseases, dementia, and autoimmune disorders, striving to deliver effective treatments worldwide.
Basic Information
Industry | pharmaceuticals |
---|---|
Founded | 2015 |
Revenue | 40.7M |
Headquarters | Philadelphia, Tennessee, 37846, United States |
Contact Details
- Phone: +1 (588) 019-0358
- Website: arctictherapeutics.com
- LinkedIn: linkedin.com/company/arctic-therapeutics-at
Key Focus Areas & Initiatives
- Drug discovery
- Genealogical database
- Precision-based drug development
- Diagnostic testing
- Genetic information
- Therapeutic development
- Pharmaceutical manufacturing
- Molecular biology
- Biobank
- Targeted therapies
- Clinical development
- Biotechnology
- Genetic sequencing
- Therapeutic pipeline
- Biopharma
- Autoimmune therapy
- Medical research
- Cystatin c amyloid angiopathy
- HCCAA
- Skin diseases
- Pharmaceuticals
- AI in medicine
- Autoimmune diseases
- Genetic research
- Biotech
- Personalized medicine
- Inflammatory skin conditions
- Autoimmune disorders
- Autoimmunity
- Biopharmaceutical
- Autoimmune uveitis
- Neurodegeneration
- Neuroscience
- Protein aggregation disorders
- Bioinformatics
- AI-driven drug development
- N-acetylcysteine
- Dementia treatments
- Protein aggregation
- Clinical trials
- Autoimmune inflammation
- Rare diseases
- Genomic risk assessment
- Neurodegenerative diseases
- Disease-modifying treatments
- Biotech innovation
- Genetic causes of disease
- Genomics
- B2B
- Research and development in the physical, engineering, and life sciences
- Patient care
- Medical
- Information technology & services
- Health care
- Health, wellness & fitness
- Hospital & health care
Technologies Used
- Amazon AWS
- Apache
- Bootstrap Framework
- Domo
- Google Font API
- Google Tag Manager
- KNIME
- Mobile Friendly
- Nginx
- Outlook
- Remote
- Route 53
- Shutterstock
- Sisense
- Ubuntu
- WordPress.org
- reCAPTCHA